Home/Syncromune/Dr. Stephen P. Dale, M.D.
DS

Dr. Stephen P. Dale, M.D.

Chief Medical Officer

Syncromune

Therapeutic Areas

Syncromune Pipeline

DrugIndicationPhase
SYNC-TMetastatic Castration-Resistant Prostate Cancer (mCRPC)Phase 2
SYNC-T PlatformMetastatic Non-Small Cell Lung Cancer (mNSCLC)Preclinical/Research